share_log

Nanobiotix (NBTX) Scheduled to Post Earnings on Wednesday

Nanobiotix (NBTX) Scheduled to Post Earnings on Wednesday

Nanobiotix定於週三公佈財報
Defense World ·  2022/09/26 01:31

Nanobiotix (NASDAQ:NBTX – Get Rating) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, September 28th. Parties interested in listening to the company's conference call can do so using this link.

Nanobiotix(納斯達克代碼：NBTX-GET Rating)計劃在9月28日週三股市收盤後發佈季度收益數據。有興趣收聽該公司電話會議的各方可以使用此鏈接進行收聽。

Nanobiotix Price Performance

Nanobiotix價格性能

Shares of NBTX opened at $3.95 on Monday. Nanobiotix has a 12-month low of $2.32 and a 12-month high of $13.37. The firm has a 50-day moving average price of $3.98 and a 200 day moving average price of $4.94.

週一，NBTX的股價開盤報3.95美元。Nanobiotix的12個月低點為2.32美元，12個月高位為13.37美元。該公司的50日移動均線價格為3.98美元，200日移動均線價格為4.94美元。

Get
到達
Nanobiotix
納米生物
alerts:
警報：

About Nanobiotix

關於納米生物製劑

(Get Rating)

(獲取評級)

Nanobiotix SA, a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer.
Nanobiotix SA是一種臨牀階段的生物技術，專注於開發治療癌症的候選產品。它的主要候選產品是NBTXR3，這是一種由晶態氧化鎢納米顆粒組成的無菌水懸浮液，用於治療軟組織肉瘤、頭頸癌、肝癌、前列腺癌、胰腺癌、食道癌、直腸癌和非小細胞肺癌。

See Also

另請參閲

  • Get a free copy of the StockNews.com research report on Nanobiotix (NBTX)
  • Can Caterpillar Claw Higher in a Falling Market?
  • Is Dave & Buster's Immune to High Inflation and Lower Spending?
  • Should These 3 Top-Performing Mid-Caps Be On Your Watchlist?
  • Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
  • MarketBeat: Week in Review 9/19 – 9/23
  • 免費獲取StockNews.com關於Nanobiotix的研究報告(NBTX)
  • 卡特彼勒能否在下跌的市場中走得更高？
  • Dave&Buster‘s能免受高通脹和低支出的影響嗎？
  • 這三隻表現最好的中型股應該出現在你的觀察名單上嗎？
  • 華爾街對Datadog的熱情會帶來巨大的收益嗎？
  • MarketBeat：回顧一週9/19-9/23

Receive News & Ratings for Nanobiotix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanobiotix and related companies with MarketBeat.com's FREE daily email newsletter.

接受Nanobiotix日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Nanobiotix和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論